An Open-label, Randomized, Controlled, 4-week Comparative Clinical Trial of Barnidipine Hydrochloride, a Calcium-channel Blocker, and Benazepril, an Angiotensin-converting Enzyme Inhibitor, in Chinese Patients with Renal Parenchymal Hypertension

By Chen X   Zheng F   Chen P   Tang L   Wei R   Yu Y   Su Y   Kikkawa T   Yamamoto M  

The Journal of International Medical Research, Vol. 34, Iss. 2, 2006-03 ,pp. : 121-128

Field House Publishing

Access to resources Recommend Favorite

Effects of an Angiotensin 2 Receptor Blocker plus Diuretic Combination Drug in Chronic Heart Failure Complicated by Hypertension

By Suzuki O   Ishii H   Kobayashi S  

The Journal of International Medical Research, Vol. 39, Iss. 4, 2011-07 ,pp. : 1420-1426

Field House Publishing

Access to resources Recommend Favorite

Azilsartan medoxomil in the treatment of hypertension: the definitive angiotensin receptor blocker?

By Barrios Vivencio   Escobar Carlos  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2249-2261

Informa Healthcare

Access to resources Recommend Favorite

The Role of Angiotensin Receptor Blocker and Calcium Channel Blocker Combination Therapy in Treating Hypertension: Focus on Recent Studies

By Chrysant Steven G.  

American Journal of Cardiovascular Drugs, Vol. 10, Iss. 5, 2010-10 ,pp. : 315-320

Adis International

Access to resources Recommend Favorite

Methods to Analyse Cost Data of Patients Who Withdraw in a Clinical Trial Setting

By Oostenbrink J.B.   Al M.J.   Mölken M.P.M.H.R-v.  

PharmacoEconomics, Vol. 21, Iss. 15, 2003-01 ,pp. : 1103-1112

Adis International

Access to resources Recommend Favorite